Francois Balloux, director of the Genetics Institute at University College London, whose work focuses on the epidemiology of infectious diseases, said cross-protection — that is, exposure to the common-cold coronaviruses triggering greater immune protection against COVID — had long been the subject of quiet speculation by experts. “This hypothesis was aired since the beginning of the pandemic but was viewed as dangerous,” he said. “People avoided talking about this in polite circles.”